How to Verify a Chinese Medical Device Registration: A Distributor's Guide to Reading an NMPA Certificate Number, Checking Validity, Scope and CancellationsA practical five-check verification workflow, certificate-number decoder, public database guide, and distribution-agreement evidence schedule for international distributors qualifying Chinese medical-device suppliers.
INSIGHTS
Research and practical buying guidance.
Browse practical buyer, technical, regulatory and evidence-led guidance across the VEMERIX knowledge library.
LATEST ARTICLES
Practical guidance from the VEMERIX team.

How Sterile Procedure Kits Are Regulated: FDA Convenience-Kit Rules, EU MDR Article 22, and the Evidence Pack an Assembler, Distributor, or OEM Buyer Must VerifyA definitive regulatory pathway, post-market recall analysis, and supplier-qualification checklist for multi-component sterile procedure trays, circumcision kits, puncture sets, and dressing packs.

What the FDA MAUDE and Recall Record Reveals About Catheter and Tube Securement Device Failures: A Post-Market Evidence Map for Securement Procurement and Supplier Screening (2015–2026)An original FDA post-market surveillance analysis of 1,125 MAUDE medical device reports, a 20-action recall record, and the 510(k)-exempt Class I regulatory baseline (21 CFR 880.5210, product codes KMK, CBH, OKC) translated into tender specifications, acceptance testing, and supplier-screening criteria for vascular-access and catheter-fixation procurement.

What the FDA MAUDE and Recall Record Reveals About Surgical Stapler Failures: A Post-Market Evidence Map for Surgical Stapler Procurement and Supplier Screening (2015–2026)An original FDA post-market surveillance analysis of 3,645 MAUDE medical device reports, Class I/II recalls, and the 2021 Class II reclassification order (21 CFR 878.4740, product code GAG) translated into tender specifications, acceptance testing, and supplier-screening criteria for disposable surgical and circumcision stapler procurement.
What the FDA MAUDE and Recall Record Reveals About Topical Tissue Adhesive Failures: A Post-Market Evidence Map for Procurement and Supplier-Qualification BuyersAn empirical analysis of 1,155 FDA MAUDE device records, 2 recalls, and 36 510(k) clearances for product code MPN, mapping surveillance failure modes to 21 CFR 878.4010 regulatory special controls, Cochrane dehiscence evidence, and buyer tender specifications.
What the FDA MAUDE and Recall Record Reveals About Circumcision Device Failures: A Post-Market Evidence Map for Circumcision Procurement and Supplier Screening (2015–2026)An original FDA surveillance analysis of 31 circumcision device 510(k) clearances, 34 recalls, and 942 MAUDE adverse-event reports (all-time; 592 in the 2015–2026 window) translated into tender acceptance criteria and supplier-vigilance questions for disposable circumcision stapler, ring, and clamp devices.
What the FDA MAUDE and Recall Record Reveals About Endovenous Laser Fiber Failures: A Post-Market Evidence Map for Vascular Procurement and Supplier ScreeningAn original FDA surveillance analysis of 186 laser fiber clearances, 68 recalls, and 114 MAUDE adverse-event reports (2023–2026) translated into vascular incoming-acceptance criteria and supplier-qualification tests.

Why Sterile Medical Devices Get Recalled: A 2015–2026 FDA Evidence Map and Supplier-Control PlaybookAn FDA evidence map of 5,543 product records and 998 recall episodes shows where sterile-device failures start—and which supplier controls buyers should demand.
Disposable Circumcision Anastomat and Stapler: Device Mechanics, Sterile-Kit Components and Lot-Acceptance Tests for Procurement and Biomedical EngineeringA component-level technical guide to the single-use circumcision anastomat and stapler: the bell-and-staple firing mechanism, what belongs in the sterile convenience kit, the staple-formation and sterile-barrier lot-acceptance tests, and the US, EU and China classification — including why no US 510(k) predicate and no WHO prequalification exist for the stapler.
Single-Use vs Reusable NPWT Pump: A Disposable-vs-Powered Procurement Decision Matrix Built on FDA Product Codes, HCPCS Reimbursement and Per-Episode CostThe FDA itself splits NPWT into reusable powered, non-powered mechanical and disposable powered single-use pumps under three different Class II product codes, and the right buy flows from exudate volume, wound complexity, care setting and reimbursement path rather than a blanket claim that disposable is better.
Thermal vs Non-Thermal Varicose Vein Ablation: A Vascular Service-Line and Distributor Technology-Selection and Supplier-Qualification Guide (EVLA Laser Fiber vs RFA vs MOCA vs Cyanoacrylate Closure)Thermal (EVLA, RFA) and non-thermal (MOCA, cyanoacrylate closure) varicose-vein ablation platforms sit on different regulatory rungs. EVLA laser fibers (FDA GEX, Class II 510(k)) and RFA/MOCA catheters (GEI/KRA, Class II 510(k)) clear by substantial equivalence, while cyanoacrylate vein closure (VenaSeal, PJQ, Class III PMA) is a single-manufacturer PMA device with zero 510(k) predicates. Evaluate regulatory fit, supplier evidence packs, and consumable workflow economics alongside clinical closure data before committing portfolio or RFQ volume.
What the FDA 510(k), Recall and MAUDE Record Reveals About Negative Pressure Wound Therapy Pump Failure Modes — and What Procurement Teams Should Specify Against (2015–2025)An original FDA surveillance analysis of 214 powered NPWT pump clearances, 48 recalls, and 5,775 MAUDE adverse-event reports (2020–2025) translated into tender acceptance criteria and supplier-vigilance questions.
1470 nm Endovenous Laser System Price & Total Cost of Ownership: A Console, Fiber, Accessory and Per-Procedure Cost FrameworkA B2B buyer guide and total-cost-of-ownership framework for clinical directors, distributors, and procurement teams evaluating 1470 nm endovenous laser ablation (EVLA) systems.
Qualifying a Circumcision Device Manufacturer or Distributor Program: CE Evidence, QMS Scope, Legal-Manufacturer Role and Registration-Document ControlA practical audit and qualification checklist for distributors and private-label buyers evaluating circumcision device manufacturers, distinguishing ISO 13485 from product-specific CE certificates, defining legal-manufacturer obligations, and protecting territory exclusivity.
Disposable Circumcision Device Bulk Price, MOQ and Landed Cost: A Quote-Normalization and Total-Cost Worksheet for Distributors and Bulk BuyersA B2B procurement framework for turning ex-works device quotes into defensible landed-cost-per-unit figures, incorporating size-mix MOQ, sterile packaging, tariff treatment, customs classification, and lot-release terms.
HOCl Hospital Disinfectant Efficacy and Concentration: Why ppm Alone Does Not Prove a Claim — A Buyer's Efficacy-Substantiation GuideA technical guide for infection-prevention and procurement buyers evaluating HOCl surface disinfectants, explaining why ppm available chlorine must be evaluated alongside pH, contact time, EPA 810.2200 test methods, and jurisdiction-specific registration.
Incisional vs Open-Wound NPWT: When Closed-Incision Evidence Cannot Be Generalized to Chronic and Open WoundsA comprehensive clinical evidence review for perioperative, clinical-engineering, and procurement committees establishing why trial outcomes for prophylactic closed-incision NPWT cannot be directly transferred to open or chronic wound care.
Medical Cyanoacrylate Adhesive Supplier Qualification: A Chemistry, Regulatory and Acceptance Guide for Bulk Tissue-Adhesive BuyersA B2B supplier-qualification framework for bulk medical cyanoacrylate tissue adhesives, covering 2-octyl vs n-butyl chemistry, 2008 FDA Class II reclassification (21 CFR 878.4010, MPN), ISO 10993 biocompatibility, moisture-sensitive aseptic filling, and lot-release acceptance.
Mesotherapy Injector Device Procurement & Acceptance: An IFU, Sterility, Repeatability and Supplier-Evidence GuideA technical procurement guide for medical device buyers, quality engineers, and aesthetic clinic directors establishing incoming acceptance criteria, sterility boundaries, delivery repeatability, and regulatory compliance for mesotherapy and auto-injector devices.
NPWT Pump Hospital Price and Total Cost of Therapy: A Transparent Pump, Consumables, Reimbursement and Downtime Cost Model (Without Inventing Vendor Prices)A hospital procurement cost model separating public reimbursement signals, tender price ranges, and consumable consumption rates from editorial cost scenarios, without inventing vendor quotes.
Silicone Scar Gel Classification and Claim Substantiation: A US (FDA), EU and China (NMPA) Decision Matrix for Distributors and OEM BuyersQualifying a silicone scar gel or sheeting product for international markets requires navigating strict claim-by-claim classification rules across the US (FDA Class I under 21 CFR 878.4025), Europe (EU MDR Class I device vs Cosmetic Regulation boundary), and China (NMPA Class II medical device filing)—where permitted intended-use language, Cochrane evidence certainty, and ISO 10993 biocompatibility requirements set the boundary between compliant commercialization and regulatory rejection.

Radiation (Gamma, Electron-Beam and X-Ray) Sterilization Validation for Single-Use Medical Devices: An ISO 11137, VDmax and FDA Evidence Guide for OEM and Private-Label BuyersQualifying a radiation-sterilized single-use device OEM requires verifying an ISO 11137 validation protocol, substantiating the 25 kGy or 15 kGy sterilization dose via VDmax, selecting the optimal modality (gamma vs e-beam vs X-ray), capping polymer maximum doses, and aligning with the 4-month dose-audit interval under ISO 11137-1:2025 and the FDA Radiation Master File Pilot.
Catheter Securement Device Selection and Sourcing: An Adhesive, Integrated, Subcutaneous-Anchor and Tissue-Adhesive Buyer's Guide with US, EU and China ClassificationA cross-jurisdiction buyer guide for medical device distributors, OEM buyers, and procurement teams evaluating catheter securement designs, regulatory classes, openFDA recall failure modes, and supplier qualification standards.
Design Transfer and Change Control for Medical Devices: A QMSR / ISO 13485 Handover and Change-Classification Checklist for Legal Manufacturers and Contract ManufacturersA practical regulatory checklist for legal manufacturers, OEM brand owners, and contract manufacturers executing design transfer and classifying post-market changes under FDA QMSR, ISO 13485, EU MDR, and NMPA.
Disposable Circumcision Device Sizing and Portfolio Selection: A Distributor and Procurement Guide for Ring, Anastomat or Stapler and Kits (Adult versus Pediatric)Matching device mechanics to clinical throughput, establishing adult and pediatric size ladders, and verifying FDA, CE, and NMPA registration evidence.
Registering and Distributing a Single-Use Endovenous Laser Fiber: A US (FDA 510(k)), EU (MDR) and China (NMPA) Registration and Market-Entry Evidence PackA market-entry regulatory guide for medical device distributors and regulatory leads preparing US FDA 510(k), EU MDR Class IIb, and China NMPA registration evidence packs for single-use 1470 nm medical laser fibers.
Endovenous Laser Fiber Specifications & Compatibility: A Buyer's Specification and RFQ Guide for 1470 nm Radial FibersA 1470 nm single-use endovenous laser fiber must be matched to the console on wavelength, connector standard (SMA905), core diameter, numerical aperture, tip geometry (radial 360° vs bare-tip), introducer French size, and regulator-cleared status (FDA GEX / 21 CFR 878.4810 Class II 510(k); NMPA Class II; EU MDR IIb). Verify console compatibility and clearance before committing volume.
Ethylene Oxide Sterilization Validation for Single-Use Medical Devices: An ISO 11135 Process, ISO 10993-7 Residual and FDA Evidence Guide for OEM and Private-Label BuyersQualifying a sterile single-use device OEM demands a validated ISO 11135 process, documented ISO 10993-7 residual dissipation profiles below 4 mg EO / 9 mg ECH for limited contact, clear parametric or BI release protocols, and a regulatory change-control strategy under the FDA Sterilization Master File pilots.
Hypochlorous Acid (HOCl) Disinfectant Classification: A US, EU and China Regulatory Decision Matrix for Medical-Device and Hygiene-Product BuyersProcuring hypochlorous acid (HOCl) disinfectants internationally requires recognizing that regulatory classification is governed by intended-use claims, concentration, and application site rather than chemical identity—navigating the US EPA pesticide vs FDA liquid sterilant split under PRN 98-2, ECHA Biocidal Products Regulation (BPR) active substance rules in Europe, and China's weixiaozheng hygiene licensing system.
Medical Device Contract Manufacturing (2026): A Buyer's Evidence Checklist for Sterile Single-Use DevicesAn ISO 13485 certificate is the opening question—not the answer.